Clinigen
Clinigen Global Access Programs specializes in the consultancy, development, management and implementation of access programs across the product lifecycle for biotechnology and pharmaceutical companies.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices….
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Genesis Research Group
Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Inizio
Welcome to Inizio. Your market-leading commercialization partner, providing tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Origins – The Patient Focused Specialists
Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value by involving patients throughout the entire product life cycle. We…
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups.
Red Thread Market Access Ltd
Blending brilliant writing with in-depth market access and reimbursement expertise
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Uniphar
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Visions4Health
Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…
Company Details
Latest Content from PMHub
Andi Goes – the children’s book that helps detect early signs of dyslexia
Press Releases | March 3, 2021 | Havas Lynx
Havas Lynx Group have launched a children’s book aimed at raising awareness and detecting early signs of dyslexia. Helping to make sure that parents have the support they need whilst...
The imperfect art of sustainable communications
Press Releases | March 2, 2021 | 11 London
Scanning the papers this last week, we’ve seen a welcome departure from wall-to-wall gloom –and very real signs of ‘Reasons To Be Cheerful’.The economy, we’re told, might not be such...
Good design saves lives
White Papers and Resources | March 2, 2021 | Page & Page Health
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics
Press Releases | March 1, 2021 | Onyx Health
Leading biotechnology company NovaBiotics Ltd have secured a major licensing deal for their fungal nail treatment
Rare Disease Day in a COVID-19 environment
Press Releases | February 28, 2021 | Lucid Group Communications Limited
For many people and families living with a rare disease, their journey can be very complex. At times, that journey can even be scary, frustrating and confusing. However, when your...
Bedrock’s strong start to 2021
Press Releases | February 26, 2021 | Resonant Group
Just two months into the year and at Bedrock we’ve already added FOUR new people to an ever-growing team!
Enabling Patient-Focused Research Through Virtual Clinical Trials
Videos and Podcasts | February 25, 2021 | Impetus Digital
Chad Walsh, CEO of Sciteline, dives into virtual trials, including their benefits, barriers, and impact on patient-centricity. Among other things, we will discuss data privacy concerns, the role of digital...
Innovative Approaches to Managing Mental Health Conditions
Videos and Podcasts | February 25, 2021 | Impetus Digital
Owen Muir, MD, CIO at Brooklyn Minds, explores the secondary effects of COVID-19 on mental health conditions, along with techniques such as deep Transcranial Magnetic Stimulation (dTMS), Mentalization-Based Treatment (MBT), and...
Newcells Biotech secures over £5m for 3D tissue models
Press Releases | February 25, 2021 | Onyx Health
Newcells Biotech have received multi-million investment to develop their pioneering 3D tissue models
Why we need to look at rare diseases in a different way
Press Releases | February 25, 2021 | Resonant Group
28 February 2021, Rare Disease Day aims to raise awareness of rare diseases and the impact they have on patients’ lives.